Drug Shortage Report for CETROTIDE

Last updated on 2022-05-24 History
Report ID 161102
Drug Identification Number 02247766
Brand name CETROTIDE
Common or Proper name Cetrorelix for Injection
Company Name EMD SERONO, A DIVISION OF EMD INC., CANADA
Market Status MARKETED
Active Ingredient(s) CETRORELIX
Strength(s) 0.25MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size Vial (2mL)
ATC code H01CC
ATC description HYPOTHALAMIC HORMONES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-05-23
Estimated end date 2022-06-30
Actual end date
Shortage status Actual shortage
Updated date 2022-05-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2695 NORTH SHERIDAN WAY, SUITE 200
MISSISSAUGA, ONTARIO
CANADA L5K 2N6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2022-05-24 English Compare
v3 2022-05-21 French Compare
v2 2022-05-21 French Compare
v1 2022-05-21 English Compare

Showing 1 to 4 of 4